White Paper
Our work in White Paper
-
The 340B Drug Pricing Program: Background, Ongoing Challenges and Recent Developments
The 340B Drug Pricing Program allows eligible healthcare clinics and hospitals (“covered entities”) to purchase outpatient drugs at a 20-50% discount.
Categorized in -
From Vision to Design in Advancing Medicare Payment Reform: A Blueprint for Population-Based Payments
With Medicare spending growth over the next decade expected to exceed GDP growth, the trust fund projected to be depleted in 2026, and evidence of persistent and pervasive waste and disparities in health care, attention has returned to the role of payment reform in controlling Medicare spending growth and driving more efficient and equitable care delivery.
-
Private Equity Investment as a Divining Rod for Market Failure: Policy Responses to Harmful Physician Practice Acquisitions
It is unclear whether private equity investment is itself a problem or whether, in the absence of private equity, other sources of capital—such as public equity, venture capital, health systems, and insurers—would similarly exploit existing market failures and legal loopholes in the healthcare system.
-
The Social Value of Disseminating Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has facilitated treatment of aortic stenosis in patients otherwise ineligible for corrective surgery or who are reluctant to undergo open-heart surgery. Schaeffer Center experts estimate the social value of past and future TAVR procedures.
Categorized in -
Advancing the Economics of Palliative Care: The Value to Individuals and Families, Organizations, and Society
A palliative care research agenda can help lay the foundation for building a strong evidence base to guide public policies meant to advance affordable, equitable, high-quality, patient-centered care.
Categorized in -
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
A new white paper published by the USC Schaeffer Center focuses on multi-cancer, early detection, (MCED) blood-based tests as one solution to reduce disparities in late-stage cancer diagnosis among minority populations.
Categorized in -
COVID-19 Vaccination Mandates for School and Work Are Sound Public Policy
A new Schaeffer Center white paper finds that vaccine mandates for employees and students is an effective policy solution to ensure the U.S. reaches herd immunity and avoids future outbreaks.
Categorized in -
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
Some claim that FDA approval of drugs with uncertain efficacy today will slow future innovation. In fact, the relationship is much more complex.
Categorized in -
Medicare Advanced Imaging Payment: Dysfunctional Policy Making
Medicare’s experience of paying for outpatient imaging services, particularly expensive advanced imaging such as MRIs, CAT scans, and nuclear scans, has been tumultuous over the last 20 years.
-
Enrollment in Nongroup Health Insurance by Income Group
Slightly more than half of those with incomes below 400% of the federal poverty level (FPL) were enrolled in nongroup policies that constitute minimum essential coverage.